|
ELF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.857400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.224200E-02 |
| Normal-vs-Stage2 |
6.216000E-01 |
| Normal-vs-Stage3 |
2.642400E-01 |
| Normal-vs-Stage4 |
1.156210E-01 |
| Stage1-vs-Stage2 |
5.619400E-01 |
| Stage1-vs-Stage3 |
2.121500E-03 |
| Stage1-vs-Stage4 |
9.638200E-04 |
| Stage2-vs-Stage3 |
2.056800E-01 |
| Stage2-vs-Stage4 |
1.155410E-01 |
| Stage3-vs-Stage4 |
5.854400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.216800E-01 |
| Normal-vs-AfricanAmerican |
6.099600E-01 |
| Normal-vs-Asian |
2.928400E-01 |
| Caucasian-vs-AfricanAmerican |
3.345000E-01 |
| Caucasian-vs-Asian |
1.482000E-01 |
| AfricanAmerican-vs-Asian |
1.543200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.253600E-01 |
| Normal-vs-Female |
6.876400E-01 |
| Male-vs-Female |
9.323800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.913800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.012760E-01 |
| Normal-vs-Age(61-80Yrs) |
5.046600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.626100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.213200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.863600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.249600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.760800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.374200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.119400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.536280E-03 |
| Normal-vs-Grade 2 |
9.157800E-03 |
| Normal-vs-Grade 3 |
1.783830E-01 |
| Normal-vs-Grade 4 |
1.037930E-02 |
| Grade 1-vs-Grade 2 |
1.825610E-01 |
| Grade 1-vs-Grade 3 |
1.959580E-04 |
| Grade 1-vs-Grade 4 |
8.40720000000461E-05 |
| Grade 2-vs-Grade 3 |
1.70960000001052E-06 |
| Grade 2-vs-Grade 4 |
4.77239999963075E-07 |
| Grade 3-vs-Grade 4 |
7.845900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.937800E-03 |
| Normal-vs-ccB subtype |
5.112600E-01 |
| ccA subtype-vs-ccB subtype |
2.979200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.077000E-01 |
| Normal-vs-N1 |
4.823600E-01 |
| N0-vs-N1 |
3.707400E-01 |
|
|
